Investigations of new lead structures for the design of selective estrogen receptor modulators

Journal of Medicinal Chemistry

Volumn 44, Issue 12, 2001, Pages 1963-1970

  Gust, R ^a   Keilitz, R ^a   Schmidt, K ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLORO 4 HYDROXYPHENYL) 2 (2,6 DICHLORO 4 HYDROXYPHENYL)ETHYLENE DIAMINE; 2 (2 CHLORO 4 HYDROXYPHENYL) 3 (2,6 DICHLORO 4 HYDROXYPHENYL)PIPERAZINE; 2 (2 CHLORO 4 HYDROXYPHENYL) 5 (2,6 DICHLORO 4 HYDROXYPHENYL) 2 IMIDAZOLINE; 4 (2 CHLORO 4 HYDROXYPHENYL) 5 (2,6 DICHLORO 4 HYDROXYPHENYL)IMIDAZOLE; AMINO ACID; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE; LEAD; LUCIFERASE; PIPERAZINE DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG DESIGN; DRUG SELECTIVITY; DRUG SYNTHESIS; HORMONE ACTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

BINDING, COMPETITIVE; BREAST NEOPLASMS; DIETHYLSTILBESTROL; DRUG DESIGN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; IMIDAZOLES; KINETICS; LUCIFERASES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PIPERAZINES; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035821599     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm001131d     Document Type: Article

References (27)

1. Ovarian hormones and the cardiovascular system: Recent findings
2. Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease
3. The role of estrogen in the prevention of osteoporosis
4. A novel human estrogen receptor beta: Identification and functional analysis of additional N-terminal amino acids
5. Functional analysis of a novel estrogen receptor-beta isoform
6. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor
7. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
8. Molecular basis of agonism and antagonism in the oestrogen receptor
9. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
10. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
11. Aqua[1-(2,6-dichloro-4-hydroxyphenyl) -2-phenylethylenediamine]sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. 1. Synthesis and antitumor and estrogenic properties
12. Aqua[1-(2,6-dichloro-4-hydroxyphenyl) -2-phenylethylenediamine]sulfatoplatinum(II) complexes with variable substituents in the 2-phenyl ring. Part II: Correlation of molecular structure and estrogenic activity of breast and prostate cancer inhibiting [erythro-1-(2,6-dichloro-4-hydroxyphenyl)-2-(2-halo-4-hydroxyphenyl) ethylenediamine]platinum(II) complexes
13. 1-Benzyl-2-phenylindole- and 1,2-diphenylindole-based antiestrogens. Estimation of agonist and antagonist activities in transfection assays
14. Biochemical pharmacology of antiestrogen action
15. The estradiol pharmacophor: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
16. X-ray conformation of some estrogens and their binding to uterine receptors
17. Receptor-based 3D QSAR analysis of estrogen receptor ligands - Merging the accuracy of receptor-based alignments with the computional efficiency of ligand-based methods
18. Hydrophobic cluster analysis (HCA) of the hormone-binding domain of receptor proteins
19. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen
20. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data
21. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach
22. Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology
23. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
24. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351
25. Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1, 2-diphenylethanes
26. Effect of growth factors on estrogen receptor mediated gene expression
27. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding